AA, T., & RG, B. (2021). In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y. Annals of internal medicine, 174(10), JC115. https://doi.org/10.7326/ACPJ202110190-115
Chicago Style (17th ed.) CitationAA, Taleb, and Badgett RG. "In Severe, Uncontrolled Asthma, Tezepelumab Reduced Exacerbations and Improved Asthma Control at 1 Y." Annals of Internal Medicine 174, no. 10 (2021): JC115. https://doi.org/10.7326/ACPJ202110190-115.
MLA (9th ed.) CitationAA, Taleb, and Badgett RG. "In Severe, Uncontrolled Asthma, Tezepelumab Reduced Exacerbations and Improved Asthma Control at 1 Y." Annals of Internal Medicine, vol. 174, no. 10, 2021, p. JC115, https://doi.org/10.7326/ACPJ202110190-115.
Warning: These citations may not always be 100% accurate.